Skip to content

Drug interactions

Erdafitinib + Estradiol

Severity: Minor

Erdafitinib and Estradiol: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Erdafitinib inhibits P-glycoprotein, and estradiol is a P-gp substrate, so estradiol exposure may rise modestly. The clinical consequence is likely small, with estrogen-related adverse effects the main concern.

What this interaction means in plain words

Erdafitinib and Estradiol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Erdafitinib belongs to Oncology; Estradiol belongs to Endocrine.

Evidence level: Low

Why it happens

Erdafitinib inhibits intestinal P-gp efflux of estradiol, which may increase its absorption.

What to do

No routine change is required; monitor for estrogen excess symptoms such as breast tenderness or fluid retention. Dose-reduce estradiol if effects appear.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Erdafitinib and Estradiol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Erdafitinib with Estradiol?

MediHelp rates the interaction as minor. Erdafitinib and Estradiol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Erdafitinib inhibits P-glycoprotein, and estradiol is a P-gp substrate, so estradiol exposure may rise modestly. The clinical consequence is likely small, with estrogen-related adverse effects the main concern.

How serious is the interaction between Erdafitinib and Estradiol?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine change is required; monitor for estrogen excess symptoms such as breast tenderness or fluid retention. Dose-reduce estradiol if effects appear.

What other medicines interact with Estradiol?

MediHelp also lists interactions of Estradiol with, for example, Anastrozole, Fezolinetant, Ospemifene. The full list is on the Estradiol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in